15/03/2019 08:00:00

Consti Group Plc - Managers' transactions - Lähteinen

CONSTI GROUP PLC   Managers Transactions on 15 March 2019 at 10.00 a.m.

Consti Group Plc - Managers' transactions - Lähteinen


Person subject to the notification requirement

Name: Lähteinen, Pirkka

Position: Other senior manager

Issuer: Consti Group Plc



Reference number: 743700JMXCC11CRJCS71_20190314092640_4


Transaction date: 2019-03-13

Instrument type: SHARE

ISIN: FI4000178256

Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details

(1): Volume: 1483 Unit price: 0.00 EUR

Aggregated transactions

(1): Volume: 1483 Volume weighted average price: 0.00 EUR


Further information:

Joni Sorsanen, CFO, Consti Group Plc, Tel. +358 50 443 3045


Nasdaq Helsinki Oy

Major media


Consti is a leading Finnish company concentrating on renovation and technical services. Consti offers comprehensive building technology, pipeline renovation, renovation contracting, façade renovation and other demanding construction and maintenance services for residential and commercial buildings. In 2018, Consti Group’s net sales amounted to 316 million euro. It employs over 1,000 professionals in renovation construction and building technology.

Consti Group Plc is listed on Nasdaq Helsinki. The trading code is CONSTI.



Related content
26 Apr - 
Changes in Consti Group’s Management Team
26 Apr - 
Consti Group Plc Interim Report for January – March 201..
02 Apr - 
Organising Meeting of the Board of Directors of Consti ..

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg


EuroInvestor: In Focus


EuroInvestor: In Focus


EuroInvestor: In Focus

Most read news

  • 24 hours
  • 48 hours
  • 1 week
OSE Immunotherapeutics Will Participate in HealthTech Investor Days (HTID)
Global Arena Holding Inc. (GAHC), Files First Quarter 10Q, and Updates Shareholders on Subsidiaries
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Eros International Plc (NYSE: EROS) and Encourages Eros Investors to Contact the Firm
Hofseth Biocare ASA: Signed Letter of Intent with Garden of Life® for exclusive use of CollaGo® and ProGo® in the US market
Final Data Analysis of Phase 2 PBC Trial Shows that Genkyotex’s Anti-fibrotic Candidate GKT831 Demonstrated Statistically Significant Improvements in GGT and ALP Over Full Treatment Period

Related stock quotes

Consti Yhtiöt Oyj 5.320 -3.6% Stock price decreasing

Latest news

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
24 June 2019 23:34:57
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190527.1 - EUROWEB2 - 2019-06-25 00:34:57 - 2019-06-24 23:34:57 - 1000 - Website: OKAY